IQVIA HOLDINGS INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 230.6 USD | -0.22% |
|
-6.09% | -0.43% |
| Apr. 10 | Lupin Launches Generic Version of Oracea (Doxycycline Capsules) in US | MT |
| Apr. 08 | Iqvia, Salesforce Collaborate to Accelerate Life Sciences Cloud Development | MT |
Presenter SpeechEric Coldwell (Analysts)Good afternoon. Thank you, everyone, for joining us. N...
Cet article est réservé aux abonnés
Déjà abonné ?
Log InPas encore abonné ?
S'abonner
Iqvia Holdings Inc. is one of the world's leading companies specializing in information, analytics, research and healthcare services based on technology solutions. Net sales break down by activity as follows:
- development of contract research and clinical development solutions and services (54.5%): helping biopharmaceutical companies, medical researchers and healthcare professionals optimize their clinical studies, develop new therapeutic classes, identify treatment needs and assess the efficacy of pharmaceuticals with a view to improving clinical and scientific outcomes;
- development of technology and analytics solutions (39.9%): services related to information, analysis, strategic consulting, marketing studies and short-term healthcare-market studies, business processes outsourcing, and management of medical-administrative databases, all aimed at optimizing the performance and commercial strategies of pharmaceutical companies and health workers;
- integrated services (5.6%): development and implementation of customized solutions and customer engagement programs, healthcare services, scientific and medical services, etc.
Net sales are distributed geographically as follows: Americas (49.4%), Europe and Africa (31.4%) and Asia/Pacific (19.2%).
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
231.2
USD
Average target price
275.4
USD
Spread / Average Target
+19.13%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -0.43% | 42.07B | |
| +48.71% | 42.16B | |
| +5.61% | 39.77B | |
| -11.36% | 26.68B | |
| +4.72% | 24.68B | |
| -23.21% | 18.68B | |
| -1.10% | 12.11B | |
| +26.85% | 11.99B | |
| +5.68% | 11.06B | |
| -16.94% | 10.3B |
- Stock Market
- Equities
- IQV Stock
- News Iqvia Holdings Inc.
- Transcript : IQVIA Holdings Inc. Presents at Baird 2022 Global Healthcare Conference, Sep-14-2022 02
